GlassScriptPhysician profile
Ying Ming Zhang
NPI 1578587440
$4,882.88
in general payments reported to CMS, 2019-2025
17 companies · $1,791 in 2025
The $1,791 reported for 2025 was more than what 88% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2020: $256 · 2021: $307 · 2022: $362 · 2023: $806 · 2024: $913 · 2025: $1,791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,509.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,115.65 | 2019-2025 | Spravato |
| Abbvie INC. | $906.98 | 2021-2025 | Vraylar |
| Axsome Therapeutics, INC. | $669.37 | 2023-2025 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $565.47 | 2020-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $345.32 | 2019-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $327.59 | 2021-2025 | Trintellix |
| Vanda Pharmaceuticals INC. | $173.72 | 2025 | Fanapt, Hetlioz |
| Alkermes, INC. | $148.38 | 2022-2024 | Lybalvi |
| Neurocrine Biosciences, INC. | $121.84 | 2019 | |
| Sunovion Pharmaceuticals INC. | $110.45 | 2020-2021 | |
| Eisai INC. | $104.34 | 2021 | |
| Supernus Pharmaceuticals, INC. | $96.02 | 2024-2025 | Qelbree |
| Allergan, INC. | $79.69 | 2020 | |
| Bausch Health US, LLC | $62.94 | 2022 | |
| Lundbeck LLC | $22.87 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $17.26 | 2022 | |
| Neos Therapeutics, LP | $14.99 | 2025 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ying Ming Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.